nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—Chronic myeloid leukaemia—Thalidomide—leprosy	0.0794	0.0844	CcSEcCtD
Busulfan—Anxiety depression—Thalidomide—leprosy	0.0456	0.0485	CcSEcCtD
Busulfan—Menopause—Thalidomide—leprosy	0.033	0.0351	CcSEcCtD
Busulfan—Tumour lysis syndrome—Thalidomide—leprosy	0.027	0.0287	CcSEcCtD
Busulfan—Acute leukaemia—Thalidomide—leprosy	0.0262	0.0278	CcSEcCtD
Busulfan—Rales—Thalidomide—leprosy	0.0182	0.0194	CcSEcCtD
Busulfan—Pericarditis—Thalidomide—leprosy	0.0173	0.0184	CcSEcCtD
Busulfan—Erythema nodosum—Thalidomide—leprosy	0.0173	0.0184	CcSEcCtD
Busulfan—Ascites—Thalidomide—leprosy	0.0165	0.0175	CcSEcCtD
Busulfan—Skin exfoliation—Dapsone—leprosy	0.014	0.0148	CcSEcCtD
Busulfan—Vesiculobullous rash—Thalidomide—leprosy	0.0133	0.0142	CcSEcCtD
Busulfan—Enlargement abdomen—Thalidomide—leprosy	0.0124	0.0132	CcSEcCtD
Busulfan—Febrile neutropenia—Thalidomide—leprosy	0.0124	0.0132	CcSEcCtD
Busulfan—Hypomagnesaemia—Thalidomide—leprosy	0.0118	0.0125	CcSEcCtD
Busulfan—GSTM1—blood vessel—leprosy	0.0116	0.195	CbGeAlD
Busulfan—Hepatomegaly—Thalidomide—leprosy	0.0106	0.0112	CcSEcCtD
Busulfan—Lung disorder—Thalidomide—leprosy	0.0106	0.0112	CcSEcCtD
Busulfan—Thrombosis—Thalidomide—leprosy	0.0106	0.0112	CcSEcCtD
Busulfan—Interstitial lung disease—Thalidomide—leprosy	0.0106	0.0112	CcSEcCtD
Busulfan—Pleural effusion—Thalidomide—leprosy	0.00977	0.0104	CcSEcCtD
Busulfan—Rash pustular—Thalidomide—leprosy	0.00938	0.00998	CcSEcCtD
Busulfan—Endocrine disorder—Thalidomide—leprosy	0.00903	0.0096	CcSEcCtD
Busulfan—Pancreatitis—Dapsone—leprosy	0.00899	0.00956	CcSEcCtD
Busulfan—Amenorrhoea—Thalidomide—leprosy	0.00852	0.00906	CcSEcCtD
Busulfan—Vasodilation procedure—Thalidomide—leprosy	0.00852	0.00906	CcSEcCtD
Busulfan—Vasodilation—Thalidomide—leprosy	0.00852	0.00906	CcSEcCtD
Busulfan—Jaundice cholestatic—Thalidomide—leprosy	0.00852	0.00906	CcSEcCtD
Busulfan—Skin discolouration—Thalidomide—leprosy	0.00828	0.00881	CcSEcCtD
Busulfan—Hyperbilirubinaemia—Thalidomide—leprosy	0.00823	0.00875	CcSEcCtD
Busulfan—Hypocalcaemia—Thalidomide—leprosy	0.00817	0.00869	CcSEcCtD
Busulfan—Oliguria—Thalidomide—leprosy	0.00812	0.00863	CcSEcCtD
Busulfan—Drug interaction—Thalidomide—leprosy	0.00807	0.00858	CcSEcCtD
Busulfan—Hyperuricaemia—Thalidomide—leprosy	0.00807	0.00858	CcSEcCtD
Busulfan—Creatinine increased—Thalidomide—leprosy	0.00786	0.00836	CcSEcCtD
Busulfan—Sinusitis—Dapsone—leprosy	0.00767	0.00816	CcSEcCtD
Busulfan—Blood uric acid increased—Thalidomide—leprosy	0.00762	0.0081	CcSEcCtD
Busulfan—Pharyngitis—Dapsone—leprosy	0.00729	0.00775	CcSEcCtD
Busulfan—Skin exfoliation—Thalidomide—leprosy	0.00714	0.0076	CcSEcCtD
Busulfan—Blood urea increased—Thalidomide—leprosy	0.00706	0.00751	CcSEcCtD
Busulfan—Aplastic anaemia—Thalidomide—leprosy	0.00703	0.00747	CcSEcCtD
Busulfan—Oesophagitis—Thalidomide—leprosy	0.00684	0.00727	CcSEcCtD
Busulfan—Rash maculo-papular—Thalidomide—leprosy	0.0068	0.00723	CcSEcCtD
Busulfan—Gynaecomastia—Thalidomide—leprosy	0.0067	0.00712	CcSEcCtD
Busulfan—Pulmonary oedema—Thalidomide—leprosy	0.00666	0.00708	CcSEcCtD
Busulfan—Sepsis—Thalidomide—leprosy	0.00649	0.00691	CcSEcCtD
Busulfan—Erythema—Dapsone—leprosy	0.00639	0.0068	CcSEcCtD
Busulfan—Dermatitis exfoliative—Thalidomide—leprosy	0.00576	0.00612	CcSEcCtD
Busulfan—Atrial fibrillation—Thalidomide—leprosy	0.00573	0.0061	CcSEcCtD
Busulfan—Dermatitis bullous—Thalidomide—leprosy	0.00568	0.00604	CcSEcCtD
Busulfan—Cough—Dapsone—leprosy	0.00558	0.00593	CcSEcCtD
Busulfan—Lethargy—Thalidomide—leprosy	0.00554	0.00589	CcSEcCtD
Busulfan—Hyponatraemia—Thalidomide—leprosy	0.00545	0.0058	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00543	0.00578	CcSEcCtD
Busulfan—MGST2—testis—leprosy	0.00539	0.0904	CbGeAlD
Busulfan—GSTM1—skin of body—leprosy	0.00538	0.0903	CbGeAlD
Busulfan—Tachycardia—Dapsone—leprosy	0.00509	0.00541	CcSEcCtD
Busulfan—Blood creatinine increased—Thalidomide—leprosy	0.00509	0.00541	CcSEcCtD
Busulfan—Hypokalaemia—Thalidomide—leprosy	0.00494	0.00526	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00489	0.0052	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Thalidomide—leprosy	0.00479	0.00509	CcSEcCtD
Busulfan—Abdominal distension—Thalidomide—leprosy	0.00473	0.00503	CcSEcCtD
Busulfan—Insomnia—Dapsone—leprosy	0.00472	0.00502	CcSEcCtD
Busulfan—Pancreatitis—Thalidomide—leprosy	0.0046	0.00489	CcSEcCtD
Busulfan—GSTA1—testis—leprosy	0.00459	0.0769	CbGeAlD
Busulfan—GSTA1—nervous system—leprosy	0.0045	0.0755	CbGeAlD
Busulfan—Pancytopenia—Thalidomide—leprosy	0.00446	0.00474	CcSEcCtD
Busulfan—Neutropenia—Thalidomide—leprosy	0.00439	0.00467	CcSEcCtD
Busulfan—Erectile dysfunction—Thalidomide—leprosy	0.00432	0.0046	CcSEcCtD
Busulfan—Weight increased—Thalidomide—leprosy	0.00427	0.00454	CcSEcCtD
Busulfan—Gastrointestinal pain—Dapsone—leprosy	0.00426	0.00453	CcSEcCtD
Busulfan—Weight decreased—Thalidomide—leprosy	0.00425	0.00452	CcSEcCtD
Busulfan—Hyperglycaemia—Thalidomide—leprosy	0.00423	0.0045	CcSEcCtD
Busulfan—Pneumonia—Thalidomide—leprosy	0.00421	0.00448	CcSEcCtD
Busulfan—Infestation NOS—Thalidomide—leprosy	0.00419	0.00445	CcSEcCtD
Busulfan—Infestation—Thalidomide—leprosy	0.00419	0.00445	CcSEcCtD
Busulfan—Depression—Thalidomide—leprosy	0.00417	0.00444	CcSEcCtD
Busulfan—Abdominal pain—Dapsone—leprosy	0.00412	0.00438	CcSEcCtD
Busulfan—Body temperature increased—Dapsone—leprosy	0.00412	0.00438	CcSEcCtD
Busulfan—Renal failure—Thalidomide—leprosy	0.00411	0.00438	CcSEcCtD
Busulfan—Stomatitis—Thalidomide—leprosy	0.00408	0.00434	CcSEcCtD
Busulfan—Haematuria—Thalidomide—leprosy	0.00399	0.00424	CcSEcCtD
Busulfan—Epistaxis—Thalidomide—leprosy	0.00395	0.0042	CcSEcCtD
Busulfan—Sinusitis—Thalidomide—leprosy	0.00393	0.00418	CcSEcCtD
Busulfan—Agranulocytosis—Thalidomide—leprosy	0.00391	0.00415	CcSEcCtD
Busulfan—GSTP1—eye—leprosy	0.00388	0.065	CbGeAlD
Busulfan—Bradycardia—Thalidomide—leprosy	0.00383	0.00407	CcSEcCtD
Busulfan—Rhinitis—Thalidomide—leprosy	0.00377	0.00401	CcSEcCtD
Busulfan—Pharyngitis—Thalidomide—leprosy	0.00373	0.00397	CcSEcCtD
Busulfan—Urinary tract disorder—Thalidomide—leprosy	0.00371	0.00395	CcSEcCtD
Busulfan—Urethral disorder—Thalidomide—leprosy	0.00368	0.00392	CcSEcCtD
Busulfan—Erythema multiforme—Thalidomide—leprosy	0.00355	0.00378	CcSEcCtD
Busulfan—Eye disorder—Thalidomide—leprosy	0.00351	0.00373	CcSEcCtD
Busulfan—Cardiac disorder—Thalidomide—leprosy	0.00349	0.00371	CcSEcCtD
Busulfan—Angiopathy—Thalidomide—leprosy	0.00341	0.00363	CcSEcCtD
Busulfan—Immune system disorder—Thalidomide—leprosy	0.00339	0.00361	CcSEcCtD
Busulfan—GSTM1—testis—leprosy	0.00339	0.0569	CbGeAlD
Busulfan—Mediastinal disorder—Thalidomide—leprosy	0.00339	0.0036	CcSEcCtD
Busulfan—GSTP1—skin of body—leprosy	0.00337	0.0565	CbGeAlD
Busulfan—Chills—Thalidomide—leprosy	0.00337	0.00359	CcSEcCtD
Busulfan—Arrhythmia—Thalidomide—leprosy	0.00336	0.00357	CcSEcCtD
Busulfan—GSTM1—nervous system—leprosy	0.00333	0.0558	CbGeAlD
Busulfan—Alopecia—Thalidomide—leprosy	0.00332	0.00353	CcSEcCtD
Busulfan—Vomiting—Dapsone—leprosy	0.00332	0.00353	CcSEcCtD
Busulfan—GSTA2—testis—leprosy	0.00331	0.0555	CbGeAlD
Busulfan—Mental disorder—Thalidomide—leprosy	0.00329	0.0035	CcSEcCtD
Busulfan—Malnutrition—Thalidomide—leprosy	0.00327	0.00348	CcSEcCtD
Busulfan—Headache—Dapsone—leprosy	0.00327	0.00347	CcSEcCtD
Busulfan—GSTA2—nervous system—leprosy	0.00325	0.0545	CbGeAlD
Busulfan—Tension—Thalidomide—leprosy	0.00321	0.00341	CcSEcCtD
Busulfan—Nervousness—Thalidomide—leprosy	0.00318	0.00338	CcSEcCtD
Busulfan—Back pain—Thalidomide—leprosy	0.00316	0.00336	CcSEcCtD
Busulfan—Nausea—Dapsone—leprosy	0.0031	0.00329	CcSEcCtD
Busulfan—Anaemia—Thalidomide—leprosy	0.00302	0.00322	CcSEcCtD
Busulfan—Agitation—Thalidomide—leprosy	0.00301	0.0032	CcSEcCtD
Busulfan—Leukopenia—Thalidomide—leprosy	0.00293	0.00311	CcSEcCtD
Busulfan—Cough—Thalidomide—leprosy	0.00285	0.00304	CcSEcCtD
Busulfan—Convulsion—Thalidomide—leprosy	0.00283	0.00301	CcSEcCtD
Busulfan—Hypertension—Thalidomide—leprosy	0.00282	0.003	CcSEcCtD
Busulfan—Chest pain—Thalidomide—leprosy	0.00278	0.00296	CcSEcCtD
Busulfan—Myalgia—Thalidomide—leprosy	0.00278	0.00296	CcSEcCtD
Busulfan—Arthralgia—Thalidomide—leprosy	0.00278	0.00296	CcSEcCtD
Busulfan—Anxiety—Thalidomide—leprosy	0.00278	0.00295	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00277	0.00294	CcSEcCtD
Busulfan—Dry mouth—Thalidomide—leprosy	0.00272	0.0029	CcSEcCtD
Busulfan—Confusional state—Thalidomide—leprosy	0.00269	0.00286	CcSEcCtD
Busulfan—Oedema—Thalidomide—leprosy	0.00267	0.00284	CcSEcCtD
Busulfan—Infection—Thalidomide—leprosy	0.00265	0.00282	CcSEcCtD
Busulfan—Nervous system disorder—Thalidomide—leprosy	0.00262	0.00278	CcSEcCtD
Busulfan—Thrombocytopenia—Thalidomide—leprosy	0.00261	0.00278	CcSEcCtD
Busulfan—Tachycardia—Thalidomide—leprosy	0.00261	0.00277	CcSEcCtD
Busulfan—Skin disorder—Thalidomide—leprosy	0.00259	0.00276	CcSEcCtD
Busulfan—GSTP1—tendon—leprosy	0.00257	0.043	CbGeAlD
Busulfan—Anorexia—Thalidomide—leprosy	0.00254	0.00271	CcSEcCtD
Busulfan—Hypotension—Thalidomide—leprosy	0.00249	0.00265	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Thalidomide—leprosy	0.00243	0.00259	CcSEcCtD
Busulfan—Insomnia—Thalidomide—leprosy	0.00241	0.00257	CcSEcCtD
Busulfan—Dyspnoea—Thalidomide—leprosy	0.00238	0.00253	CcSEcCtD
Busulfan—Somnolence—Thalidomide—leprosy	0.00237	0.00252	CcSEcCtD
Busulfan—Dyspepsia—Thalidomide—leprosy	0.00235	0.0025	CcSEcCtD
Busulfan—Decreased appetite—Thalidomide—leprosy	0.00232	0.00247	CcSEcCtD
Busulfan—Gastrointestinal disorder—Thalidomide—leprosy	0.0023	0.00245	CcSEcCtD
Busulfan—Fatigue—Thalidomide—leprosy	0.0023	0.00245	CcSEcCtD
Busulfan—Pain—Thalidomide—leprosy	0.00228	0.00243	CcSEcCtD
Busulfan—Constipation—Thalidomide—leprosy	0.00228	0.00243	CcSEcCtD
Busulfan—Feeling abnormal—Thalidomide—leprosy	0.0022	0.00234	CcSEcCtD
Busulfan—Gastrointestinal pain—Thalidomide—leprosy	0.00218	0.00232	CcSEcCtD
Busulfan—GSTP1—testis—leprosy	0.00213	0.0356	CbGeAlD
Busulfan—Urticaria—Thalidomide—leprosy	0.00212	0.00226	CcSEcCtD
Busulfan—Abdominal pain—Thalidomide—leprosy	0.00211	0.00224	CcSEcCtD
Busulfan—Body temperature increased—Thalidomide—leprosy	0.00211	0.00224	CcSEcCtD
Busulfan—GSTP1—nervous system—leprosy	0.00209	0.035	CbGeAlD
Busulfan—Hypersensitivity—Thalidomide—leprosy	0.00197	0.00209	CcSEcCtD
Busulfan—Asthenia—Thalidomide—leprosy	0.00192	0.00204	CcSEcCtD
Busulfan—Pruritus—Thalidomide—leprosy	0.00189	0.00201	CcSEcCtD
Busulfan—Diarrhoea—Thalidomide—leprosy	0.00183	0.00194	CcSEcCtD
Busulfan—Dizziness—Thalidomide—leprosy	0.00177	0.00188	CcSEcCtD
Busulfan—Vomiting—Thalidomide—leprosy	0.0017	0.00181	CcSEcCtD
Busulfan—Rash—Thalidomide—leprosy	0.00168	0.00179	CcSEcCtD
Busulfan—Dermatitis—Thalidomide—leprosy	0.00168	0.00179	CcSEcCtD
Busulfan—Headache—Thalidomide—leprosy	0.00167	0.00178	CcSEcCtD
Busulfan—Nausea—Thalidomide—leprosy	0.00159	0.00169	CcSEcCtD
Busulfan—CYP3A4—nervous system—leprosy	0.00085	0.0143	CbGeAlD
